ASB1
Ankyrin repeat and SOCS box protein 1
Also known as: ASB-1, ASB1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y576
- Gene
- ASB1
- Ensembl
- ENSG00000065802
- Chromosome
- 2
- Canonical length
- 335 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene contains an ankyrin repeat sequence and SOCS box domain. The SOCS box serves to couple suppressor of cytokine signalling (SOCS) proteins and their binding partners with the elongin B and C complex, targeting them for ubiquitination and degradation. [provided by RefSeq, Aug 2016]
Canonical amino-acid sequenceUniProt
335 residues, UniProt reviewed canonical sequence.
>Q9Y576|ASB1
1 MAEGGSPDGR AGPGSAGRNL KEWLREQFCD HPLEHCEDTR LHDAAYVGDL QTLRSLLQEE
61 SYRSRINEKS VWCCGWLPCT PLRIAATAGH GSCVDFLIRK GAEVDLVDVK GQTALYVAVV
121 NGHLESTQIL LEAGADPNGS RHHRSTPVYH ASRVGRADIL KALIRYGADV DVNHHLTPDV
181 QPRFSRRLTS LVVCPLYISA AYHNLQCFRL LLLAGANPDF NCNGPVNTQG FYRGSPGCVM
241 DAVLRHGCEA AFVSLLVEFG ANLNLVKWES LGPESRGRRK VDPEALQVFK EARSVPRTLL
301 CLCRVAVRRA LGKHRLHLIP SLPLPDPIKK FLLHELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ASB1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- tongue: 22 nTPM
- skeletal muscle: 20 nTPM
- spinal cord: 20 nTPM
- midbrain: 18 nTPM
- amygdala: 16 nTPM
- basal ganglia: 16 nTPM
Single-cell type
- late primary spermatocytes: 62 nCPM
- cardiomyocytes: 53 nCPM
- differentiating spermatogonia: 44 nCPM
- early primary spermatocytes: 38 nCPM
- extravillous trophoblasts: 38 nCPM
- epicardial cells: 36 nCPM
Immune cell
- memory B-cell: 4.3 nTPM
- gdT-cell: 4.2 nTPM
- memory CD8 T-cell: 4.1 nTPM
- T-reg: 4.1 nTPM
- memory CD4 T-cell: 3 nTPM
- naive CD8 T-cell: 3 nTPM
Brain region
- midbrain: 37 nTPM
- pons: 35 nTPM
- spinal cord: 34 nTPM
- hypothalamus: 34 nTPM
- amygdala: 34 nTPM
- thalamus: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.27
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intracellular signal transduction
- male genitalia development
- negative regulation of cytokine production
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein ubiquitination
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SOCS box domain
- Ankyrin repeat
- SOCS box-like domain superfamily
- Ankyrin repeat-containing domain superfamily
- SOCS box
- Ankyrin repeats (3 copies)
- Ankyrin repeat
- Ankyrin repeat and SOCS box protein 1, SOCS box domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ASB1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ASB1 as an antibody target. Whether an autoantibody or antibody against ASB1 could matter depends on whether native ASB1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ASB1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ASB1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...